Login
$GBFH
$17.06 -$0.41 (2.32%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
ASSETS
Cash and due from banks
Interest-bearing deposits with other financial institutions
Total cash and cash equivalents
Available for sale, at fair value (amortized cost of $117,538 at June 30, 2026 and $71,061 at December 31, 2025)
Held to maturity, at amortized cost (fair value of $38,856 at September 30, 2025 and $40,392 at December 31, 2024)
Loans held for sale
Loans, net of deferred fees and costs
Less: Allowance for credit losses
Loans, net
Premises and equipment, net
Operating lease right-of-use asset
Bank-owned life insurance
Loan servicing assets, net
Federal Home Loan Bank stock, at cost
Other real estate owned
Other assets
Total Assets
LIABILITIES AND STOCKHOLDERS' EQUITY
Deposits:
Noninterest-bearing demand
Interest-bearing demand
Savings
Time
Total deposits
Short-term borrowings
Subordinated Debt
Operating lease liability
Other liabilities
Total liabilities
Stockholders' Equity:
Common stock, par value $0.0001; 80,000,000 shares authorized; 14,470,352 shares issued and outstanding at June 30, 2026 and 14,385,226 shares issued and outstanding at December 31, 2025
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Total Stockholders' Equity
Total Liabilities and Stockholders' Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support